Immucell Corp.
ICCC
Get informed when a big investor buys or sells
+ FollowMarket Cap$92.64M
Close$
$6.58
33.3% downside
Current Fair Value
33.3% downsideOvervalued by 33.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $92.64 Million |
|---|---|
| Enterprise Value | $91.53 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.12 |
| Beta | 0.5 |
| Outstanding Shares | 9,045,977 |
Return
| Return on Equity | -1.87% |
|---|---|
| Return on Assets | -1.24% |
| Return on Invested Capital | 6.37% |
Valuation & Multiples
| P/E Ratio | -169.84 |
|---|---|
| PEG | 170.07 |
| Price to Sales | 3.29 |
| Price to Book Ratio | 3.29 |
| Enterprise Value to Revenue | 3.06 |
| Enterprise Value to EBIT | 35.76 |
| Enterprise Value to Net Income | -168 |
| Total Debt to Enterprise | 0.06 |
| Debt to Equity | 0.2 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 20, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 13, 2026
EPS Estimate
$0.05
Average shareholder expectationRevenue Estimate
$5.40 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 15.17%▲ 1.02% |
|---|---|
| Total Invested | $8.67M▲ 10.05% |
| Investors Holding | 27▲ 1.00% |
ESG Score
No data
About Immucell Corp.
CEO: Michael Brigham